KING STEVEN W 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Nov 1, 2017
Insider Transaction Report
Form 4
KING STEVEN W
DirectorPresident & CEO
Transactions
- Other
Common Stock
2017-10-31$3.87/sh+1,398$5,407→ 34,646 total
Footnotes (1)
- [F1]Shares acquired under the issuer's employee stock purchase plan on October 31, 2017.